National Healthcare Corp
NYSE American:NHC

  • LAST PRICE
    127.0800
  • TODAY'S CHANGE (%)
    0.6000 (0.4744%)
  • Bid / Lots
    123.1000/ 1
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    128.3600 / 126.4800
  • Day Range
    127.0800
    129.9500
  • 52 Week Range
    75.5300
    138.4900
  • Volume
    57,499

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 8, 2024

      Show headlines and story abstract

    • 6:25AM ET on Friday Nov 08, 2024 by MT Newswires
      Companies Mentioned: NHC
      06:25 AM EST, 11/08/2024 (MT Newswires) -- National HealthCare (NHC) reported Q3 adjusted earnings Friday of $1.27 per diluted share, up from $0.86 a year earlier. Revenue for the quarter ended Sept. 30 was $340.2 million, compared with $288.5 mill...

    • 6:01AM ET on Friday Nov 08, 2024 by MT Newswires
      Companies Mentioned: NHC
      06:01 AM EST, 11/08/2024 (MT Newswires) -- ...

    • 6:00AM ET on Friday Nov 08, 2024 by MT Newswires
      Companies Mentioned: NHC
      06:00 AM EST, 11/08/2024 (MT Newswires) -- ...

    • 6:00AM ET on Friday Nov 08, 2024 by Dow Jones
      Companies Mentioned: NHC
      $248.51 and 95,030 patient days. The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): Three Months Ended Nine Months Ended September 30 September 30 -------------------- ----------------------------- 2024 2023 2024 2023 ------- ------- --------- --------- (unaudited) (unaudited) Net income attributable to National Healthcare Corporation $ 42,789 $ 10,388 $ 95,846 $ 38,392 Non-GAAP adjustments Unrealized (gains)/losses on marketable equity securities (32,767) 3,093 (56,290) (2,943) Operating results for newly opened operations not at full capacity (2) 120 66 140 1,616 Stock-based compensation expense 1,093 708 3,062 2,119 Gain on sale of unconsolidated company - - (1,024) - Acquisition-related expenses (3) 637 - 2,831 - Employee retention credit - - (9,445) - Income tax provision on non-GAAP adjustments 8,038 (1,005) 15,789 (206) ------- ------- --------- --------- Non-GAAP Net income $ 19,910 $ 13,250 $ 50,909 $ 38,978 ======= ======= ========= ========= GAAP diluted earnings per share $ 2.73 $ 0.68 $ 6.15 $ 2.51 Non-GAAP adjustments Unrealized (gains)/losses on marketable equity securities (1.55) 0.15 (2.67) (0.14) Operating results for newly opened operations not at full capacity (2) 0.01 - 0.01 0.07 Stock-based compensation expense 0.05 0.03 0.15 0.10 Gain on sale of unconsolidated company - - (0.05) - Acquisition-related expenses (3) 0.03 - 0.13 - Employee retention credit - - (0.45) - ------- ------- --------- --------- Non-GAAP diluted earnings per share $ 1.27 $ 0.86 $ 3.27 $ 2.54 ======= ======= ========= ========= (2) The operating results for newly opened facilities or agencies not at full capacity include healthcare operations that are still considered in the start-up phase, which are two hospice agencies for the three and nine months ended September 30, 3024. For the three and nine months ended September 30, 2023, included are two behavioral health hospitals, two homecare agencies, and two hospice agencies. (3) Represents expenses incurred to acquire the White Oak operations that are not capitalizable.

    • 6:00AM ET on Friday Nov 08, 2024 by Dow Jones
      Companies Mentioned: NHC

Peers Headlines